TCL Archive Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation May 9, 2014
TCL Archive Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles. September 7, 2001
TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977